These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 34198312)
21. Tri-Cyclic Nucleobase Analogs and their Ribosides as Substrates of Purine-Nucleoside Phosphorylases. II Guanine and Isoguanine Derivatives. Stachelska-Wierzchowska A; Wierzchowski J; Górka M; Bzowska A; Wielgus-Kutrowska B Molecules; 2019 Apr; 24(8):. PubMed ID: 30995785 [TBL] [Abstract][Full Text] [Related]
22. Site-Selective Ribosylation of Fluorescent Nucleobase Analogs Using Purine-Nucleoside Phosphorylase as a Catalyst: Effects of Point Mutations. Stachelska-Wierzchowska A; Wierzchowski J; Bzowska A; Wielgus-Kutrowska B Molecules; 2015 Dec; 21(1):E44. PubMed ID: 26729076 [TBL] [Abstract][Full Text] [Related]
23. Conformational states of human purine nucleoside phosphorylase at rest, at work, and with transition state analogues. Edwards AA; Tipton JD; Brenowitz MD; Emmett MR; Marshall AG; Evans GB; Tyler PC; Schramm VL Biochemistry; 2010 Mar; 49(9):2058-67. PubMed ID: 20108972 [TBL] [Abstract][Full Text] [Related]
24. Chemoenzymatic synthesis of cytokinins from nucleosides: ribose as a blocking group. Oslovsky VE; Solyev PN; Polyakov KM; Alexeev CS; Mikhailov SN Org Biomol Chem; 2018 Mar; 16(12):2156-2163. PubMed ID: 29520402 [TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of a series of truncated neplanocin fleximers. Zimmermann SC; O'Neill E; Ebiloma GU; Wallace LJ; De Koning HP; Seley-Radtke KL Molecules; 2014 Dec; 19(12):21200-14. PubMed ID: 25521119 [TBL] [Abstract][Full Text] [Related]
26. 6-Methylpurine derived sugar modified nucleosides: Synthesis and evaluation of their substrate activity with purine nucleoside phosphorylases. Hassan AE; Abou-Elkhair RA; Parker WB; Allan PW; Secrist JA Bioorg Chem; 2016 Apr; 65():9-16. PubMed ID: 26745284 [TBL] [Abstract][Full Text] [Related]
27. Substrate specificity of uridine and purine nucleoside phosphorylases of the whole cells of Escherichia coli. Zintchenko AI; Eroshevskaya LA; Barai VN; Mikhailopulo IA Nucleic Acids Symp Ser; 1987; (18):137-40. PubMed ID: 3122186 [TBL] [Abstract][Full Text] [Related]
29. Calf spleen purine nucleoside phosphorylase complexed with substrates and substrate analogues. Mao C; Cook WJ; Zhou M; Federov AA; Almo SC; Ealick SE Biochemistry; 1998 May; 37(20):7135-46. PubMed ID: 9585525 [TBL] [Abstract][Full Text] [Related]
30. Expedient and generic synthesis of imidazole nucleosides by enzymatic transglycosylation. Vichier-Guerre S; Dugué L; Bonhomme F; Pochet S Org Biomol Chem; 2016 Apr; 14(14):3638-53. PubMed ID: 26986701 [TBL] [Abstract][Full Text] [Related]
31. Two fluorogenic substrates for purine nucleoside phosphorylase, selective for mammalian and bacterial forms of the enzyme. Wierzchowski J; Stachelska-Wierzchowska A; Wielgus-Kutrowska B; Mikleušević G Anal Biochem; 2014 Feb; 446():25-7. PubMed ID: 24140360 [TBL] [Abstract][Full Text] [Related]
32. Crystallographic snapshots of ligand binding to hexameric purine nucleoside phosphorylase and kinetic studies give insight into the mechanism of catalysis. Štefanić Z; Narczyk M; Mikleušević G; Kazazić S; Bzowska A; Luić M Sci Rep; 2018 Oct; 8(1):15427. PubMed ID: 30337572 [TBL] [Abstract][Full Text] [Related]
33. Efficient Fludarabine-Activating PNP From Archaea as a Guidance for Redesign the Active Site of E. Coli PNP. Cacciapuoti G; Bagarolo ML; Martino E; Scafuri B; Marabotti A; Porcelli M J Cell Biochem; 2016 May; 117(5):1126-35. PubMed ID: 26477689 [TBL] [Abstract][Full Text] [Related]
35. Open and closed conformation of the E. coli purine nucleoside phosphorylase active center and implications for the catalytic mechanism. Koellner G; Bzowska A; Wielgus-Kutrowska B; Luić M; Steiner T; Saenger W; Stepiński J J Mol Biol; 2002 Jan; 315(3):351-71. PubMed ID: 11786017 [TBL] [Abstract][Full Text] [Related]
36. Recombinant bacterial cells as efficient biocatalysts for the production of nucleosides. Spoldi E; Ghisotti D; Calì S; Grisa M; Orsini G; Tonon G; Zuffi G Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):977-9. PubMed ID: 11563158 [TBL] [Abstract][Full Text] [Related]
37. Studies of inhibitor binding to Escherichia coli purine nucleoside phosphorylase using the transferred nuclear Overhauser effect and rotating-frame nuclear Overhauser enhancement. Perlman ME; Davis DG; Koszalka GW; Tuttle JV; London RE Biochemistry; 1994 Jun; 33(24):7547-59. PubMed ID: 8011620 [TBL] [Abstract][Full Text] [Related]
38. Designer gene therapy using an Escherichia coli purine nucleoside phosphorylase/prodrug system. Bennett EM; Anand R; Allan PW; Hassan AE; Hong JS; Levasseur DN; McPherson DT; Parker WB; Secrist JA; Sorscher EJ; Townes TM; Waud WR; Ealick SE Chem Biol; 2003 Dec; 10(12):1173-81. PubMed ID: 14700625 [TBL] [Abstract][Full Text] [Related]
39. Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis. Stoeckler JD; Poirot AF; Smith RM; Parks RE; Ealick SE; Takabayashi K; Erion MD Biochemistry; 1997 Sep; 36(39):11749-56. PubMed ID: 9305964 [TBL] [Abstract][Full Text] [Related]
40. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Hughes BW; Wells AH; Bebok Z; Gadi VK; Garver RI; Parker WB; Sorscher EJ Cancer Res; 1995 Aug; 55(15):3339-45. PubMed ID: 7614469 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]